Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2565656-70-2
2. Muvalaplin [usan]
3. Ly3473329
4. Hsu2ky4efk
5. Unii-hsu2ky4efk
6. Ly-3473329
7. Muvalaplin (usan)
8. Who 12607
9. (2s,2's,2''s)-3,3',3''-((nitrilotris(methylene))tris(benzene-3,1-diyl))tris(2-((r)-pyrrolidin-3-yl)propanoic Acid)
10. (2s)-3-[3-[[bis[[3-[(2s)-2-carboxy-2-[(3r)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]methyl]phenyl]-2-[(3r)-pyrrolidin-3-yl]propanoic Acid
11. 3-pyrrolidineacetic Acid, Alpha,alpha',alpha''- (nitrilotris(methylene-3,1-phenylenemethylene))tris-,(alphas,alpha's,alpha''s,3r,3'r,3''r)-
12. Muvalaplin [inn]
13. Chembl4802585
14. Schembl22750411
15. Gtpl12939
16. Glxc-27761
17. Ex-a9182
18. At43355
19. Da-65716
20. Hy-152857
21. Cs-0641200
22. D12460
23. (13r,2s,10s,113r)-6-[(3-{(2s)-2-carboxy-2-[(3r)-pyrrolidin-3-yl]ethyl}phenyl)methyl]-6-aza-1,11(3)-dipyrrolidina-4,8(1,3)-dibenzenaundecaphane-2,10-dicarboxylic Acid
24. (2s)-3-[3-[[bis[[3-[(2s)-2-carboxy-2-[(3r)-pyrrolidin-3-yl]ethyl]phenyl]methyl]amino]phenyl]-2-[(3r)-pyrrolidin-3-yl]propanoic Acid
25. 3-pyrrolidineacetic Acid, Alpha,alpha',alpha''- [nitrilotris(methylene-3,1-phenylenemethylene)]tris-, (alphas,alpha's,alpha''s,3r,3'r,3''r)-
| Molecular Weight | 710.9 g/mol |
|---|---|
| Molecular Formula | C42H54N4O6 |
| XLogP3 | -2.8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 18 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 151 |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1020 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
46
PharmaCompass offers a list of Muvalaplin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Muvalaplin manufacturer or Muvalaplin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Muvalaplin manufacturer or Muvalaplin supplier.
PharmaCompass also assists you with knowing the Muvalaplin API Price utilized in the formulation of products. Muvalaplin API Price is not always fixed or binding as the Muvalaplin Price is obtained through a variety of data sources. The Muvalaplin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Muvalaplin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Muvalaplin, including repackagers and relabelers. The FDA regulates Muvalaplin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Muvalaplin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Muvalaplin supplier is an individual or a company that provides Muvalaplin active pharmaceutical ingredient (API) or Muvalaplin finished formulations upon request. The Muvalaplin suppliers may include Muvalaplin API manufacturers, exporters, distributors and traders.
Muvalaplin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Muvalaplin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Muvalaplin GMP manufacturer or Muvalaplin GMP API supplier for your needs.
A Muvalaplin CoA (Certificate of Analysis) is a formal document that attests to Muvalaplin's compliance with Muvalaplin specifications and serves as a tool for batch-level quality control.
Muvalaplin CoA mostly includes findings from lab analyses of a specific batch. For each Muvalaplin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Muvalaplin may be tested according to a variety of international standards, such as European Pharmacopoeia (Muvalaplin EP), Muvalaplin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Muvalaplin USP).
